Why big pharma wants to collect 2 million genomes
For the head of AstraZeneca’s genomics initiative, the challenge is not just getting the sequences, but in putting them to use — wisely.
Send us a link
Outlook on "Precision Medicine"
A nature Outlook collection of articles on "Precision Medicine"
OpenTrials launch date
OpenTrials will officially launch its beta on Monday 10th October 2016 at the World Health Summit in Berlin.
Replications, ridicule and a recluse
As failures to replicate results using the CRISPR alternative stack up, a quiet scientist stands by his claims.
Progress lies in precision
If we want to achieve the ambitions set out by the United Nations for global health and development by 2030, we need to bring two worlds closer together through a new concept—precision public health.
In CRISPR Fight, Co-Inventor Says Broad Institute Misled Patent Office
New evidence in the battle to control a gene-editing technology that is worth billions.
Make Data Sharing Routine to Prepare for Public Health Emergencies
Jean-Paul Chretien and colleagues argue that recent Ebola and Zika virus outbreaks highlight the importance of data sharing in scientific research.
×